We are live on ! Find out more
CTKB icon

Cytek Biosciences
CTKB

54 hedge funds and large institutions have $744M invested in Cytek Biosciences in 2021 Q3 according to their latest regulatory filings, with 54 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

25.69% more ownership

Funds ownership: 0% → 25.69% (+26%)

Holders
54
Holders Change
+54
Holders Change %
–
% of All Funds
0.95%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
% of All Funds
0.04%
New
54
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
RCM
RA Capital Management
Massachusetts
+$226M
2
HA
HHLR Advisors
Cayman Islands
+$206M
3
Fidelity International
Fidelity International
Bermuda
+$62.7M
4
Fidelity Investments
Fidelity Investments
Massachusetts
+$62.7M
5
MGM
Miura Global Management
New York
+$49.8M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
RCM
1
RA Capital Management
Massachusetts
$206M +$226M +9,607,028 New
HA
2
HHLR Advisors
Cayman Islands
$187M +$206M +8,757,030 New
Fidelity International
3
Fidelity International
Bermuda
$57.1M +$62.7M +2,666,600 New
Fidelity Investments
4
Fidelity Investments
Massachusetts
$57.1M +$62.7M +2,666,600 New
MGM
5
Miura Global Management
New York
$45.3M +$49.8M +2,117,500 New
O
6
OrbiMed
New York
$41.2M +$45.2M +1,923,139 New
BlackRock
7
BlackRock
New York
$39.7M +$43.6M +1,854,743 New
Vanguard Group
8
Vanguard Group
Pennsylvania
$25.6M +$28.1M +1,196,372 New
OCA
9
Octagon Capital Advisors
New York
$10.7M +$11.8M +500,000 New
RFA
10
Reilly Financial Advisors
California
$10.6M +$1.88M +79,979 New
PVI
11
Pura Vida Investments
New York
$9.51M +$10.5M +444,368 New
DCM
12
Driehaus Capital Management
Illinois
$9.45M +$10.4M +441,518 New
SAM
13
Sectoral Asset Management
Quebec, Canada
$7.02M +$7.72M +328,080 New
Geode Capital Management
14
Geode Capital Management
Massachusetts
$6.87M +$7.55M +321,108 New
State Street
15
State Street
Massachusetts
$4.44M +$4.88M +207,439 New
Millennium Management
16
Millennium Management
New York
$3.83M +$4.21M +178,978 New
Northern Trust
17
Northern Trust
Illinois
$3.08M +$3.38M +143,859 New
FAM
18
Fred Alger Management
New York
$2.42M +$2.66M +112,980 New
Charles Schwab
19
Charles Schwab
California
$2.21M +$2.42M +102,990 New
CCM
20
CAAS Capital Management
New York
$2.14M +$2.35M +100,000 New
Ameriprise
21
Ameriprise
Minnesota
$1.88M +$2.06M +87,634 New
Alyeska Investment Group
22
Alyeska Investment Group
Illinois
$1.61M +$1.76M +75,000 New
Goldman Sachs
23
Goldman Sachs
New York
$1.48M +$1.63M +69,322 New
Norges Bank
24
Norges Bank
Norway
$1.31M +$1.44M +61,390 New
GCM
25
Ghisallo Capital Management
Massachusetts
$1.07M +$1.18M +50,000 New
1
2 3

CTKB Hedge Fund Activity: Q3 2021 in Review

54 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Cytek Biosciences (CTKB) for Q3 2021, worth a combined $744M.

Buyers outnumbered sellers: 54 funds opened new CTKB positions and 0 closed out — a net gain of 54 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was RA Capital Management, opening a new position worth an estimated $226M.

  • 54 institutional investors held Cytek Biosciences (CTKB) as of Q3 2021, up from 0 in Q2 2021.
  • Funds reported $744M of Cytek Biosciences stock for Q3 2021.
  • 54 funds opened new Cytek Biosciences positions in Q3 2021 and 0 closed out, a net change of +54 holders.
  • The largest Cytek Biosciences buyer in Q3 2021 was RA Capital Management, an estimated $226M added.

Based on aggregated 13F filings for Q3 2021.